Stacy Wheeler

New Capabilities

Leading commercial rollout of Hovilpri

The Food and Drug Administration approved Hovilpri (pritelivir) on October 9 for persistent herpes sores in adults with weakened immune systems. It is the first herpes treatment with a new mechanism of action in nearly 30 years.

Updated Oct 16